AC141272.1 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
AC233755.2 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
ACAP1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA2R | Annexin A2 receptor | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP15 | Rho GTPase activating protein 15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ARL11 | ADP-ribosylation factor-like 11 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCAS4 | Breast carcinoma amplified sequence 4 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C12orf77 | Chromosome 12 open reading frame 77 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCL17 | Chemokine (C-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD28 | CD28 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD3D | CD3d molecule, delta (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD3G | CD3g molecule, gamma (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD5 | CD5 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD84 | CD84 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD96 | CD96 molecule | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CETP | Cholesteryl ester transfer protein, plasma | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHMP7 | Charged multivesicular body protein 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CLEC2D | C-type lectin domain family 2, member D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4C | C-type lectin domain family 4, member C | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC9A | C-type lectin domain family 9, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLECL1 | C-type lectin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLLU1OS | Chronic lymphocytic leukemia up-regulated 1 opposite strand | Predicted intracellular proteins
| | | | | Tissue enhanced |
CRTAM | Cytotoxic and regulatory T cell molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CTB-133G6.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |